Author

R. H. Daw

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

J. E. Konkel· 2 shared J. R. Grainger· 2 shared A. D. Adamson· 1 shared C. Chew· 1 shared C. L. Scott· 1 shared E. M. Hessel· 1 shared H. Bridgeman· 1 shared I. E. Prise· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. E. Konkel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD163 and Tim-4 identify resident intestinal macrophages across sub-tissular regions that are spatially regulated by TGF-β

I. E. Prise, V. Jayaraman, V. Kästele, R. H. Daw, K. Wemyss, H. Bridgeman, S. Tamburrano, P. Strangward, C. Chew, L. Martens, C. L. Scott, M. Guilliams, A. D. Adamson, J. E. Konkel, T. N. Shaw, J. R. Grainger

The paper identifies CD163 and Tim-4 as markers for intestinal macrophages and shows TGF-β regulates their spatial distribution in different niches.

bioRxiv · Aug 21, 2023Immunology

Distinct eosinophil subsets are modulated by agonists of the commensal-metabolite and vitamin B3 receptor GPR109A during allergic-type inflammation

R. Azzoni, K. J. Filbey, R. H. Daw, M. Z. Krauss, M. R. Hepworth, J. E. Konkel, E. M. Hessel, Y. Kannan, J. R. Grainger

The paper identifies GPR109A as a regulator of glycolytic Siglec-Fhi eosinophils during allergic inflammation, showing that GPR109A ligands reduce their frequency and activation.

bioRxiv · Aug 4, 2022 · PreprintImmunology